Digital life sciences company Mend raised $15 million in a series A financing round.
Mend offers digital behavioral health services, nutrapharma products and a text-messaging-based platform that allows hospitals to track patient recovery. The company plans to use the new financing to execute its contracts, scale its products and accelerate research, according to a June 6 Mend news release.
Healthcare-focused investment firm S2G Ventures led the funding round.
"Through this funding, Mend will have the opportunity to invest in transforming the patient care model to enhance healing, recovery and introduce proactive measures to improve human health and reduce the burden of lifestyle preventable illness," Mend CEO and co-founder Eziah Syed said in the release.